Wilczak et al. [12] performed immunohistochemical analysis on a tissue microarray of 11152 prostate cancer specimens and showed that MSH6 overexpression is common in prostate cancer and is associated with poor survival prognosis and genetic instability. Here, MSH6 is linked to prostate carcinoma.